Patients experiencing muscle cramps while taking GLP-1 medications should ensure adequate hydration based on individual needs
If further improvement in glycemic control or weight management is required, the dose is recommended to be increased in 2.5 mg increments after at least four weeks of treatment at the current dose
The progression from 2.5 mg to 12.5 mg follows this typical pattern: weeks 1-4 at 2.5 mg, weeks 5-8 at 5 mg, weeks 9-12 at 7.5 mg, weeks 13-16 at 10 mg, and week 17 onward at 12.5 mg
Researchers are advised to consult all relevant literature for guidelines on the exact courses of therapy
Early study showed that exendin-4 induces diverse responses including depolarization, hyperpolarization, and no response in paraventricular hypothalamic neurons
Take injections consistently on the same day each week, rotating injection sites